ONTOLOGY REPORT - ANNOTATIONS
| Term: | univalent carboacyl group |
|
| Accession: | CHEBI:27207
|
browse the term
|
| Definition: | A univalent carboacyl group is a group formed by loss of OH from the carboxy group of a carboxylic acid. |
| Synonyms: | related_synonym: | univalent acyl group; univalent carboacyl groups; univalent carboxylic acyl groups |
|
|
argipressin
|
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Myl9 |
myosin, light chain 9, regulatory |
|
increases phosphorylation |
EXP |
3 |
147,190,252 |
147,193,865 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
decreases response to substance |
ISO |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
bacitracin
|
| G |
A2m |
alpha-2-macroglobulin |
|
increases expression |
EXP |
4 |
158,103,711 |
158,153,423 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
increases expression |
EXP |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Bmp1 |
bone morphogenetic protein 1 |
|
increases expression |
EXP |
15 |
50,878,144 |
50,922,313 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
decreases expression |
EXP |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Calb1 |
calbindin 1 |
|
decreases expression |
EXP |
5 |
30,455,665 |
30,480,122 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Cd24 |
CD24 molecule |
|
increases expression |
EXP |
20 |
47,502,354 |
47,507,663 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
increases expression |
EXP |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
increases expression |
EXP |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
increases expression |
EXP |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Ctss |
cathepsin S |
|
increases expression |
EXP |
2 |
190,425,290 |
190,466,877 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
decreases expression |
EXP |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
affects expression |
EXP |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
decreases expression |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
decreases expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
affects expression |
EXP |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
increases expression |
EXP |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
increases expression |
EXP |
10 |
31,834,519 |
31,858,019 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox2 |
heme oxygenase (decycling) 2 |
|
increases expression |
EXP |
10 |
10,914,157 |
10,929,448 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
EXP |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
increases expression |
EXP |
3 |
11,511,402 |
11,514,747 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
increases expression |
EXP |
4 |
173,910,595 |
173,913,917 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Nphs2 |
nephrosis 2, idiopathic, steroid-resistant |
|
decreases expression |
EXP |
13 |
71,296,482 |
71,308,868 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
increases expression |
EXP |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin (senescence marker protein-30) |
|
decreases expression |
EXP |
X |
13,037,171 |
13,052,846 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
decreases expression |
EXP |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
decreases expression |
EXP |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Tmsb10 |
thymosin, beta 10 |
|
increases expression |
EXP |
4 |
106,286,030 |
106,287,089 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
EXP |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
increases expression |
EXP |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
beta-endorphin
|
| G |
Crh |
corticotropin releasing hormone |
|
decreases secretion |
EXP |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
multiple interactions |
EXP |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
bivalirudin
|
| G |
Crp |
C-reactive protein, pentraxin-related |
|
decreases expression |
ISO |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
decreases activity |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
decreases activity |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
decreases activity |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
increases cleavage |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
decreases activity |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
decreases activity |
ISO |
2 |
25,985,800 |
25,989,072 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
decreases expression |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
P2ry12 |
purinergic receptor P2Y, G-protein coupled, 12 |
|
affects response to substance |
ISO |
2 |
148,611,035 |
148,613,985 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
affects expression |
EXP |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
affects expression |
EXP |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Selp |
selectin P |
|
multiple interactions |
ISO |
13 |
79,886,614 |
79,922,180 |
RGD:6480464 |
CTD |
calcitonin
|
| G |
Hcrt |
hypocretin |
|
decreases expression |
EXP |
10 |
89,699,633 |
89,700,847 |
RGD:6480464 |
CTD |
| G |
Pmch |
pro-melanin-concentrating hormone |
|
decreases expression |
EXP |
7 |
24,778,133 |
24,779,449 |
RGD:6480464 |
CTD |
corticotropin
|
| G |
Ada |
adenosine deaminase |
|
increases activity |
ISO |
3 |
154,636,530 |
154,660,637 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases abundance |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
decreases activity |
EXP |
10 |
89,519,421 |
89,525,978 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
multiple interactions |
EXP |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
| G |
Crh |
corticotropin releasing hormone |
|
increases secretion |
EXP |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
multiple interactions |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
multiple interactions |
EXP |
15 |
55,463,743 |
55,532,293 |
RGD:6480464 |
CTD |
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
affects expression |
EXP |
15 |
55,463,743 |
55,532,293 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
affects abundance |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
|
multiple interactions |
ISO |
10 |
87,121,889 |
87,131,587 |
RGD:6480464 |
CTD |
| G |
Ucn2 |
urocortin 2 |
|
increases abundance |
ISO |
8 |
114,003,817 |
114,005,366 |
RGD:6480464 |
CTD |
cosyntropin
|
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
decreases expression |
ISO |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
cyclosporin A
|
| G |
A1cf |
APOBEC1 complementation factor |
|
decreases expression |
ISO |
1 |
235,865,843 |
235,958,065 |
RGD:6480464 |
CTD |
| G |
A2m |
alpha-2-macroglobulin |
|
decreases expression |
ISO |
4 |
158,103,711 |
158,153,423 |
RGD:6480464 |
CTD |
| G |
Aacs |
acetoacetyl-CoA synthetase |
|
increases expression |
ISO |
12 |
32,206,863 |
32,250,583 |
RGD:6480464 |
CTD |
| G |
Aadac |
arylacetamide deacetylase |
|
decreases expression |
ISO |
2 |
149,348,935 |
149,360,181 |
RGD:6480464 |
CTD |
| G |
Aamdc |
adipogenesis associated, Mth938 domain containing |
|
decreases expression |
ISO |
1 |
154,786,525 |
154,817,248 |
RGD:6480464 |
CTD |
| G |
Aars |
alanyl-tRNA synthetase |
|
increases expression |
ISO |
19 |
40,952,408 |
40,974,425 |
RGD:6480464 |
CTD |
| G |
Aass |
aminoadipate-semialdehyde synthase |
|
decreases expression |
ISO |
4 |
49,479,938 |
49,539,782 |
RGD:6480464 |
CTD |
| G |
Abat |
4-aminobutyrate aminotransferase |
|
decreases expression |
ISO |
10 |
7,040,725 |
7,137,154 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
decreases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
multiple interactions |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca12 |
ATP-binding cassette, subfamily A (ABC1), member 12 |
|
increases expression |
ISO |
9 |
70,328,327 |
70,501,128 |
RGD:6480464 |
CTD |
| G |
Abca2 |
ATP-binding cassette, subfamily A (ABC1), member 2 |
|
decreases expression |
ISO |
3 |
3,595,423 |
3,615,328 |
RGD:6480464 |
CTD |
| G |
Abca5 |
ATP-binding cassette, subfamily A (ABC1), member 5 |
|
decreases expression |
ISO |
10 |
99,724,778 |
99,793,593 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
affects export |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
decreases expression |
ISO |
8 |
124,305,097 |
124,313,887 |
RGD:6480464 |
CTD |
| G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
|
decreases expression |
ISO |
18 |
71,587,259 |
71,632,610 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
decreases expression |
ISO |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-CoA carboxylase beta |
|
decreases expression |
ISO |
12 |
43,388,679 |
43,492,993 |
RGD:6480464 |
CTD |
| G |
Acad11 |
acyl-CoA dehydrogenase family, member 11 |
|
decreases expression |
ISO |
8 |
109,124,763 |
109,190,186 |
RGD:6480464 |
CTD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
decreases expression |
ISO |
9 |
65,613,130 |
65,651,775 |
RGD:6480464 |
CTD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
decreases expression |
EXP |
9 |
65,613,130 |
65,651,775 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
decreases expression |
ISO |
2 |
251,866,645 |
251,890,729 |
RGD:6480464 |
CTD |
| G |
Acadsb |
acyl-CoA dehydrogenase, short/branched chain |
|
decreases expression |
ISO |
1 |
190,987,657 |
191,026,275 |
RGD:6480464 |
CTD |
| G |
Acap2 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 |
|
increases expression |
ISO |
11 |
71,411,706 |
71,524,828 |
RGD:6480464 |
CTD |
| G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
|
decreases expression |
ISO |
8 |
57,044,478 |
57,072,970 |
RGD:6480464 |
CTD |
| G |
Acbd3 |
acyl-CoA binding domain containing 3 |
|
increases expression |
ISO |
13 |
96,461,327 |
96,490,328 |
RGD:6480464 |
CTD |
| G |
Acbd4 |
acyl-CoA binding domain containing 4 |
|
decreases expression |
ISO |
10 |
92,276,972 |
92,285,988 |
RGD:6480464 |
CTD |
| G |
Acbd5 |
acyl-CoA binding domain containing 5 |
|
decreases expression |
ISO |
17 |
96,677,365 |
96,716,091 |
RGD:6480464 |
CTD |
| G |
Acbd6 |
acyl-CoA binding domain containing 6 |
|
increases expression |
ISO |
13 |
70,519,376 |
70,654,968 |
RGD:6480464 |
CTD |
| G |
Acd |
adrenocortical dysplasia homolog (mouse) |
|
increases expression |
ISO |
19 |
35,530,557 |
35,533,249 |
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Acly |
ATP citrate lyase |
|
decreases expression |
ISO |
10 |
89,420,934 |
89,471,398 |
RGD:6480464 |
CTD |
| G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
|
decreases expression |
ISO |
13 |
40,547,366 |
40,573,698 |
RGD:6480464 |
CTD |
| G |
Acn9 |
ACN9 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
4 |
32,132,528 |
32,151,053 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
decreases expression |
ISO |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Acot12 |
acyl-CoA thioesterase 12 |
|
decreases expression |
ISO |
2 |
21,984,849 |
22,035,224 |
RGD:6480464 |
CTD |
| G |
Acot4 |
acyl-CoA thioesterase 4 |
|
decreases expression |
ISO |
6 |
108,075,508 |
108,080,792 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
decreases expression |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Acox2 |
acyl-CoA oxidase 2, branched chain |
|
decreases expression |
ISO |
15 |
18,645,349 |
18,677,855 |
RGD:6480464 |
CTD |
| G |
Acox2 |
acyl-CoA oxidase 2, branched chain |
|
decreases expression |
EXP |
15 |
18,645,349 |
18,677,855 |
RGD:6480464 |
CTD |
| G |
Acp2 |
acid phosphatase 2, lysosomal |
|
decreases expression |
ISO |
3 |
75,559,522 |
75,568,415 |
RGD:6480464 |
CTD |
| G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Acpl2 |
acid phosphatase-like 2 |
|
decreases expression |
ISO |
8 |
101,917,842 |
101,983,158 |
RGD:6480464 |
CTD |
| G |
Acsf2 |
acyl-CoA synthetase family member 2 |
|
decreases expression |
ISO |
10 |
83,194,326 |
83,238,284 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
decreases expression |
ISO |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
|
increases expression |
ISO |
9 |
78,083,239 |
78,106,933 |
RGD:6480464 |
CTD |
| G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
|
decreases expression |
ISO |
1 |
261,554,383 |
261,599,373 |
RGD:6480464 |
CTD |
| G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
|
decreases expression |
ISO |
1 |
178,054,386 |
178,081,751 |
RGD:6480464 |
CTD |
| G |
Acsm5 |
acyl-CoA synthetase medium-chain family member 5 |
|
decreases expression |
ISO |
1 |
177,785,186 |
177,808,572 |
RGD:6480464 |
CTD |
| G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
|
decreases expression |
ISO |
3 |
146,013,995 |
146,057,119 |
RGD:6480464 |
CTD |
| G |
Acss3 |
acyl-CoA synthetase short-chain family member 3 |
|
decreases expression |
ISO |
7 |
45,646,821 |
45,833,803 |
RGD:6480464 |
CTD |
| G |
Actn4 |
actinin alpha 4 |
|
decreases expression |
ISO |
1 |
84,000,723 |
84,073,767 |
RGD:6480464 |
CTD |
| G |
Actr3 |
ARP3 actin-related protein 3 homolog (yeast) |
|
increases expression |
ISO |
13 |
37,861,558 |
37,904,589 |
RGD:6480464 |
CTD |
| G |
Acvr1 |
activin A receptor, type I |
|
increases expression |
ISO |
3 |
40,191,727 |
40,260,488 |
RGD:6480464 |
CTD |
| G |
Acvr1c |
activin A receptor, type IC |
|
decreases expression |
ISO |
3 |
40,027,228 |
40,102,303 |
RGD:6480464 |
CTD |
| G |
Acy1 |
aminoacylase 1 |
|
decreases expression |
ISO |
8 |
111,576,888 |
111,581,571 |
RGD:6480464 |
CTD |
| G |
Acy3 |
aspartoacylase (aminocyclase) 3 |
|
decreases expression |
ISO |
1 |
206,569,504 |
206,572,833 |
RGD:6480464 |
CTD |
| G |
Acyp1 |
acylphosphatase 1, erythrocyte (common) type |
|
affects expression |
ISO |
6 |
109,320,444 |
109,327,303 |
RGD:6480464 |
CTD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
increases expression |
ISO |
6 |
41,882,432 |
41,930,755 |
RGD:6480464 |
CTD |
| G |
Adamts3 |
ADAM metallopeptidase with thrombospondin type 1, motif 3 |
|
decreases expression |
ISO |
14 |
19,756,887 |
19,963,451 |
RGD:6480464 |
CTD |
| G |
Adamtsl4 |
ADAMTS-like 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adat1 |
adenosine deaminase, tRNA-specific 1 |
|
decreases expression |
ISO |
19 |
41,902,820 |
41,926,545 |
RGD:6480464 |
CTD |
| G |
Adck3 |
aarF domain containing kinase 3 |
|
decreases expression |
ISO |
13 |
95,869,376 |
95,896,742 |
RGD:6480464 |
CTD |
| G |
Adcy7 |
adenylate cyclase 7 |
|
increases expression |
ISO |
19 |
20,051,639 |
20,073,861 |
RGD:6480464 |
CTD |
| G |
Adcy8 |
adenylate cyclase 8 (brain) |
|
decreases expression |
ISO |
7 |
101,957,807 |
102,210,346 |
RGD:6480464 |
CTD |
| G |
Add1 |
adducin 1 (alpha) |
|
decreases expression |
ISO |
14 |
81,750,430 |
81,808,919 |
RGD:6480464 |
CTD |
| G |
Add3 |
adducin 3 (gamma) |
|
decreases expression |
ISO |
1 |
259,347,673 |
259,455,407 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
decreases expression |
ISO |
2 |
235,799,396 |
235,811,584 |
RGD:6480464 |
CTD |
| G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
decreases expression |
ISO |
2 |
235,952,313 |
235,970,671 |
RGD:6480464 |
CTD |
| G |
Adh6a |
alcohol dehydrogenase 6A (class V) |
|
decreases expression |
ISO |
2 |
235,842,525 |
235,850,491 |
RGD:6480464 |
CTD |
| G |
Adi1 |
acireductone dioxygenase 1 |
|
decreases expression |
ISO |
6 |
46,552,589 |
46,559,551 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
increases expression |
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Adnp2 |
ADNP homeobox 2 |
|
increases expression |
ISO |
18 |
77,017,502 |
77,041,570 |
RGD:6480464 |
CTD |
| G |
Adora2b |
adenosine A2B receptor |
|
increases expression |
ISO |
10 |
48,421,592 |
48,437,967 |
RGD:6480464 |
CTD |
| G |
Adprhl2 |
ADP-ribosylhydrolase like 2 |
|
increases expression |
ISO |
5 |
145,685,493 |
145,690,767 |
RGD:6480464 |
CTD |
| G |
Adprm |
ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent |
|
increases expression |
ISO |
10 |
53,738,762 |
53,751,242 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenoceptor alpha 1A |
|
decreases expression |
ISO |
15 |
46,173,429 |
46,263,198 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
decreases expression |
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrm1 |
adhesion regulating molecule 1 |
|
increases expression |
ISO |
3 |
169,229,036 |
169,233,798 |
RGD:6480464 |
CTD |
| G |
Adss |
adenylosuccinate synthase |
|
increases expression |
ISO |
13 |
93,681,036 |
93,711,373 |
RGD:6480464 |
CTD |
| G |
Adssl1 |
adenylosuccinate synthase like 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Aen |
apoptosis enhancing nuclease |
|
increases expression |
ISO |
1 |
134,615,998 |
134,625,367 |
RGD:6480464 |
CTD |
| G |
Aldoc |
aldolase C, fructose-bisphosphate |
|
decreases expression |
ISO |
10 |
64,308,826 |
64,312,415 |
RGD:6480464 |
CTD |
| G |
Alg6 |
ALG6, alpha-1,3-glucosyltransferase |
|
decreases expression |
ISO |
5 |
120,404,086 |
120,453,774 |
RGD:6480464 |
CTD |
| G |
Alg8 |
ALG8, alpha-1,3-glucosyltransferase |
|
decreases expression |
ISO |
1 |
154,607,442 |
154,628,227 |
RGD:6480464 |
CTD |
| G |
Alkbh2 |
alkB, alkylation repair homolog 2 (E. coli) |
|
decreases expression |
ISO |
12 |
43,531,682 |
43,536,317 |
RGD:6480464 |
CTD |
| G |
Alkbh3 |
alkB, alkylation repair homolog 3 (E. coli) |
|
increases expression |
ISO |
3 |
78,386,098 |
78,418,432 |
RGD:6480464 |
CTD |
| G |
Alms1 |
Alstrom syndrome 1 |
|
increases expression |
ISO |
4 |
119,846,037 |
119,946,085 |
RGD:6480464 |
CTD |
| G |
Aloxe3 |
arachidonate lipoxygenase 3 |
|
increases expression |
ISO |
10 |
55,885,573 |
55,908,641 |
RGD:6480464 |
CTD |
| G |
Alpk2 |
alpha-kinase 2 |
|
increases expression |
ISO |
18 |
61,562,696 |
61,587,804 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
decreases expression |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Amacr |
alpha-methylacyl-CoA racemase |
|
decreases expression |
ISO |
2 |
60,332,292 |
60,344,326 |
RGD:6480464 |
CTD |
| G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
decreases expression |
ISO |
5 |
80,119,742 |
80,129,962 |
RGD:6480464 |
CTD |
| G |
Amdhd1 |
amidohydrolase domain containing 1 |
|
decreases expression |
ISO |
7 |
30,557,367 |
30,572,599 |
RGD:6480464 |
CTD |
| G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
|
decreases expression |
ISO |
7 |
135,966,794 |
135,969,747 |
RGD:6480464 |
CTD |
| G |
Ammecr1l |
AMME chromosomal region gene 1-like |
|
increases expression |
ISO |
18 |
24,175,222 |
24,198,139 |
RGD:6480464 |
CTD |
| G |
Ampd3 |
adenosine monophosphate deaminase 3 |
|
increases expression |
ISO |
1 |
168,519,462 |
168,568,291 |
RGD:6480464 |
CTD |
| G |
Amph |
amphiphysin |
|
decreases expression |
ISO |
17 |
53,558,804 |
53,802,936 |
RGD:6480464 |
CTD |
| G |
Amz2 |
archaelysin family metallopeptidase 2 |
|
increases expression |
ISO |
10 |
98,889,302 |
98,899,839 |
RGD:6480464 |
CTD |
| G |
Anapc15 |
anaphase promoting complex subunit 15 |
|
decreases expression |
ISO |
1 |
159,357,727 |
159,361,360 |
RGD:6480464 |
CTD |
| G |
Ang |
angiogenin, ribonuclease, RNase A family, 5 |
|
affects expression |
ISO |
15 |
27,083,089 |
27,083,526 |
RGD:6480464 |
CTD |
| G |
Angpt1 |
angiopoietin 1 |
|
decreases expression |
ISO |
7 |
78,195,504 |
78,451,471 |
RGD:6480464 |
CTD |
| G |
Angptl3 |
angiopoietin-like 3 |
|
decreases expression |
ISO |
5 |
119,479,669 |
119,484,358 |
RGD:6480464 |
CTD |
| G |
Ank3 |
ankyrin 3, node of Ranvier (ankyrin G) |
|
decreases expression |
ISO |
20 |
19,328,684 |
19,828,196 |
RGD:6480464 |
CTD |
| G |
Ankef1 |
ankyrin repeat and EF-hand domain containing 1 |
|
increases expression |
ISO |
3 |
124,609,149 |
124,645,194 |
RGD:6480464 |
CTD |
| G |
Ankhd1 |
ankyrin repeat and KH domain containing 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ankib1 |
ankyrin repeat and IBR domain containing 1 |
|
increases expression |
ISO |
4 |
27,048,963 |
27,172,970 |
RGD:6480464 |
CTD |
| G |
Ankle2 |
ankyrin repeat and LEM domain containing 2 |
|
increases expression |
ISO |
12 |
46,563,828 |
46,595,794 |
RGD:6480464 |
CTD |
| G |
Ankrd11 |
ankyrin repeat domain 11 |
|
increases expression |
ISO |
19 |
53,208,631 |
53,242,478 |
RGD:6480464 |
CTD |
| G |
Ankrd12 |
ankyrin repeat domain 12 |
|
increases expression |
ISO |
9 |
104,746,476 |
104,823,263 |
RGD:6480464 |
CTD |
| G |
Ankrd27 |
ankyrin repeat domain 27 (VPS9 domain) |
|
increases expression |
ISO |
1 |
88,117,683 |
88,139,762 |
RGD:6480464 |
CTD |
| G |
Ankrd28 |
ankyrin repeat domain 28 |
|
increases expression |
ISO |
16 |
7,166,559 |
7,248,739 |
RGD:6480464 |
CTD |
| G |
Ankrd29 |
ankyrin repeat domain 29 |
|
decreases expression |
ISO |
18 |
3,791,224 |
3,846,087 |
RGD:6480464 |
CTD |
| G |
Ankrd32 |
ankyrin repeat domain 32 |
|
decreases expression |
ISO |
2 |
4,361,776 |
4,469,805 |
RGD:6480464 |
CTD |
| G |
Ankrd37 |
ankyrin repeat domain 37 |
|
affects expression |
ISO |
16 |
49,549,527 |
49,552,416 |
RGD:6480464 |
CTD |
| G |
Ankrd39 |
ankyrin repeat domain 39 |
|
decreases expression |
ISO |
9 |
35,481,261 |
35,491,148 |
RGD:6480464 |
CTD |
| G |
Ankrd46 |
ankyrin repeat domain 46 |
|
decreases expression |
ISO |
7 |
71,986,088 |
72,007,057 |
RGD:6480464 |
CTD |
| G |
Anlnl1 |
anillin, actin binding protein-like 1 |
|
decreases expression |
ISO |
17 |
68,547,371 |
68,559,629 |
RGD:6480464 |
CTD |
| G |
Ano10 |
anoctamin 10 |
|
increases expression |
ISO |
8 |
121,978,317 |
122,095,649 |
RGD:6480464 |
CTD |
| G |
Anp32a |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A |
|
decreases expression |
ISO |
8 |
66,488,188 |
66,523,421 |
RGD:6480464 |
CTD |
| G |
Anp32b |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
|
increases expression |
ISO |
5 |
63,044,718 |
63,058,038 |
RGD:6480464 |
CTD |
| G |
Anp32e |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
|
increases expression |
ISO |
2 |
190,715,685 |
190,730,204 |
RGD:6480464 |
CTD |
| G |
Anpep |
alanyl (membrane) aminopeptidase |
|
decreases expression |
ISO |
1 |
135,600,751 |
135,619,208 |
RGD:6480464 |
CTD |
| G |
Anpep |
alanyl (membrane) aminopeptidase |
|
increases secretion |
EXP |
1 |
135,600,751 |
135,619,208 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
increases expression |
ISO |
1 |
223,478,436 |
223,494,455 |
RGD:6480464 |
CTD |
| G |
Anxa10 |
annexin A10 |
|
decreases expression |
ISO |
16 |
30,713,142 |
30,782,020 |
RGD:6480464 |
CTD |
| G |
Anxa11 |
annexin A11 |
|
decreases expression |
ISO |
16 |
1,449,907 |
1,496,053 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
increases expression |
ISO |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
increases expression |
ISO |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Anxa9 |
annexin A9 |
|
decreases expression |
ISO |
2 |
190,206,342 |
190,215,046 |
RGD:6480464 |
CTD |
| G |
Aox1 |
aldehyde oxidase 1 |
|
decreases expression |
ISO |
9 |
56,693,698 |
56,774,115 |
RGD:6480464 |
CTD |
| G |
Ap1ar |
adaptor-related protein complex 1 associated regulatory protein |
|
increases expression |
ISO |
2 |
225,085,891 |
225,117,932 |
RGD:6480464 |
CTD |
| G |
Ap1b1 |
adaptor-related protein complex 1, beta 1 subunit |
|
decreases expression |
ISO |
14 |
85,663,840 |
85,695,487 |
RGD:6480464 |
CTD |
| G |
Ap1m1 |
adaptor-related protein complex 1, mu 1 subunit |
|
decreases expression |
ISO |
16 |
18,009,300 |
18,024,765 |
RGD:6480464 |
CTD |
| G |
Ap1s1 |
adaptor-related protein complex 1, sigma 1 subunit |
|
decreases expression |
ISO |
12 |
20,907,855 |
20,918,301 |
RGD:6480464 |
CTD |
| G |
Ap3d1 |
adaptor-related protein complex 3, delta 1 subunit |
|
increases expression |
ISO |
7 |
10,480,810 |
10,516,163 |
RGD:6480464 |
CTD |
| G |
Ap3m2 |
adaptor-related protein complex 3, mu 2 subunit |
|
increases expression |
ISO |
16 |
73,687,443 |
73,704,278 |
RGD:6480464 |
CTD |
| G |
Ap4b1 |
adaptor-related protein complex 4, beta 1 subunit |
|
increases expression |
ISO |
2 |
199,034,351 |
199,046,334 |
RGD:6480464 |
CTD |
| G |
Apba3 |
amyloid beta (A4) precursor protein-binding, family A, member 3 |
|
increases expression |
ISO |
7 |
9,930,024 |
9,934,446 |
RGD:6480464 |
CTD |
| G |
Apbb1ip |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
|
decreases expression |
ISO |
17 |
96,476,962 |
96,527,635 |
RGD:6480464 |
CTD |
| G |
Apcdd1l |
adenomatosis polyposis coli down-regulated 1-like |
|
increases expression |
ISO |
3 |
164,678,877 |
164,755,318 |
RGD:6480464 |
CTD |
| G |
Apcs |
amyloid P component, serum |
|
decreases expression |
ISO |
13 |
89,112,845 |
89,113,641 |
RGD:6480464 |
CTD |
| G |
Apeh |
N-acylaminoacyl-peptide hydrolase |
|
decreases expression |
ISO |
8 |
113,353,151 |
113,362,263 |
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa5 |
apolipoprotein A-V |
|
decreases expression |
ISO |
8 |
49,253,538 |
49,255,777 |
RGD:6480464 |
CTD |
| G |
Aspa |
aspartoacylase |
|
decreases expression |
ISO |
10 |
60,178,509 |
60,199,207 |
RGD:6480464 |
CTD |
| G |
Asph |
aspartate-beta-hydroxylase |
|
increases expression |
ISO |
5 |
23,495,780 |
23,520,672 |
RGD:6480464 |
CTD |
| G |
Asphd2 |
aspartate beta-hydroxylase domain containing 2 |
|
increases expression |
ISO |
19 |
14,362,089 |
14,373,336 |
RGD:6480464 |
CTD |
| G |
Aspm |
asp (abnormal spindle) homolog, microcephaly associated (Drosophila) |
|
decreases expression |
ISO |
13 |
52,811,658 |
52,860,925 |
RGD:6480464 |
CTD |
| G |
Asrgl1 |
asparaginase like 1 |
|
decreases expression |
ISO |
1 |
211,788,145 |
211,808,943 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
decreases expression |
ISO |
3 |
10,578,717 |
10,622,332 |
RGD:6480464 |
CTD |
| G |
Asun |
asunder, spermatogenesis regulator |
|
increases expression |
ISO |
4 |
184,121,971 |
184,152,890 |
RGD:6480464 |
CTD |
| G |
Atad2 |
ATPase family, AAA domain containing 2 |
|
decreases expression |
ISO |
7 |
94,808,296 |
94,851,986 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
increases phosphorylation |
EXP |
3 |
56,403,676 |
56,496,473 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
increases expression |
ISO |
3 |
56,403,676 |
56,496,473 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
increases expression |
ISO |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atg10 |
autophagy related 10 |
|
decreases expression |
ISO |
2 |
21,076,289 |
21,374,627 |
RGD:6480464 |
CTD |
| G |
Atg13 |
autophagy related 13 |
|
increases expression |
ISO |
3 |
76,056,642 |
76,090,287 |
RGD:6480464 |
CTD |
| G |
Atg3 |
autophagy related 3 |
|
increases expression |
ISO |
11 |
57,162,205 |
57,190,568 |
RGD:6480464 |
CTD |
| G |
Atl1 |
atlastin GTPase 1 |
|
decreases expression |
ISO |
6 |
91,979,260 |
92,077,664 |
RGD:6480464 |
CTD |
| G |
Atl3 |
atlastin GTPase 3 |
|
increases expression |
ISO |
1 |
210,177,817 |
210,219,558 |
RGD:6480464 |
CTD |
| G |
Atox1 |
ATX1 antioxidant protein 1 homolog (yeast) |
|
decreases expression |
ISO |
10 |
40,858,190 |
40,873,226 |
RGD:6480464 |
CTD |
| G |
Atp10d |
ATPase, class V, type 10D |
|
increases expression |
ISO |
14 |
38,340,037 |
38,433,736 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
decreases expression |
ISO |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases expression |
ISO |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
|
increases expression |
ISO |
7 |
36,493,661 |
36,600,280 |
RGD:6480464 |
CTD |
| G |
Atp5b |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
|
decreases expression |
ISO |
7 |
1,376,552 |
1,383,228 |
RGD:6480464 |
CTD |
| G |
Atp5c1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 |
|
decreases expression |
ISO |
17 |
79,738,999 |
79,761,176 |
RGD:6480464 |
CTD |
| G |
Atp5d |
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit |
|
decreases expression |
ISO |
7 |
11,072,820 |
11,075,906 |
RGD:6480464 |
CTD |
| G |
Atp5f1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 |
|
decreases expression |
ISO |
2 |
201,195,390 |
201,206,585 |
RGD:6480464 |
CTD |
| G |
Atp5g1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) |
|
decreases expression |
ISO |
10 |
84,788,650 |
84,791,230 |
RGD:6480464 |
CTD |
| G |
Atp5g3 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9) |
|
decreases expression |
ISO |
3 |
56,511,747 |
56,514,204 |
RGD:6480464 |
CTD |
| G |
Atp5i |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E |
|
decreases expression |
ISO |
14 |
1,867,344 |
1,868,472 |
RGD:6480464 |
CTD |
| G |
Atp5j2 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2 |
|
decreases expression |
ISO |
12 |
9,735,171 |
9,741,496 |
RGD:6480464 |
CTD |
| G |
Atp5l |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G |
|
decreases expression |
ISO |
8 |
47,869,992 |
47,876,824 |
RGD:6480464 |
CTD |
| G |
Atp6v0a1 |
ATPase, H+ transporting, lysosomal V0 subunit A1 |
|
decreases expression |
ISO |
10 |
89,948,286 |
90,072,304 |
RGD:6480464 |
CTD |
| G |
Atp6v0a2 |
ATPase, H+ transporting, lysosomal V0 subunit A2 |
|
increases expression |
ISO |
12 |
33,061,611 |
33,092,421 |
RGD:6480464 |
CTD |
| G |
Atp6v0b |
ATPase, H+ transporting, lysosomal V0 subunit B |
|
increases expression |
ISO |
5 |
138,349,548 |
138,351,064 |
RGD:6480464 |
CTD |
| G |
Atp6v0e2 |
ATPase, H+ transporting V0 subunit e2 |
|
decreases expression |
ISO |
4 |
76,621,828 |
76,624,976 |
RGD:6480464 |
CTD |
| G |
Atp6v1a |
ATPase, H+ transporting, lysosomal V1 subunit A |
|
decreases expression |
ISO |
11 |
58,127,307 |
58,180,225 |
RGD:6480464 |
CTD |
| G |
Atp6v1e2 |
ATPase, H transporting, lysosomal V1 subunit E2 |
|
increases expression |
ISO |
6 |
10,391,729 |
10,395,647 |
RGD:6480464 |
CTD |
| G |
Atp6v1g1 |
ATPase, H transporting, lysosomal V1 subunit G1 |
|
increases expression |
ISO |
5 |
80,515,635 |
80,521,815 |
RGD:6480464 |
CTD |
| G |
Atp7b |
ATPase, Cu++ transporting, beta polypeptide |
|
decreases expression |
ISO |
16 |
74,607,988 |
74,680,080 |
RGD:6480464 |
CTD |
| G |
Atp8b1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
|
decreases expression |
ISO |
18 |
60,748,738 |
60,829,650 |
RGD:6480464 |
CTD |
| G |
Atp8b2 |
ATPase, aminophospholipid transporter, class I, type 8B, member 2 |
|
increases expression |
ISO |
2 |
182,160,571 |
182,181,525 |
RGD:6480464 |
CTD |
| G |
Atp9a |
ATPase, class II, type 9A |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Atpaf1 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
|
decreases expression |
ISO |
5 |
136,049,177 |
136,075,532 |
RGD:6480464 |
CTD |
| G |
Atpbd4 |
ATP binding domain 4 |
|
increases expression |
ISO |
3 |
100,397,745 |
100,536,300 |
RGD:6480464 |
CTD |
| G |
Atpif1 |
ATPase inhibitory factor 1 |
|
decreases expression |
ISO |
5 |
152,618,307 |
152,622,024 |
RGD:6480464 |
CTD |
| G |
Auh |
AU RNA binding protein/enoyl-CoA hydratase |
|
decreases expression |
ISO |
17 |
18,147,850 |
18,251,863 |
RGD:6480464 |
CTD |
| G |
Aurka |
aurora kinase A |
|
decreases expression |
ISO |
3 |
163,270,479 |
163,284,506 |
RGD:6480464 |
CTD |
| G |
Aurkb |
aurora kinase B |
|
decreases expression |
ISO |
10 |
55,798,710 |
55,804,367 |
RGD:6480464 |
CTD |
| G |
Auts2 |
autism susceptibility candidate 2 |
|
decreases expression |
ISO |
12 |
25,518,248 |
25,541,023 |
RGD:6480464 |
CTD |
| G |
Aven |
apoptosis, caspase activation inhibitor |
|
increases expression |
ISO |
3 |
98,404,029 |
98,475,755 |
RGD:6480464 |
CTD |
| G |
Avpi1 |
arginine vasopressin-induced 1 |
|
decreases expression |
ISO |
1 |
248,727,385 |
248,733,112 |
RGD:6480464 |
CTD |
| G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
|
decreases expression |
ISO |
12 |
17,492,913 |
17,498,949 |
RGD:6480464 |
CTD |
| G |
Azi2 |
5-azacytidine induced 2 |
|
increases expression |
ISO |
8 |
122,961,302 |
122,985,601 |
RGD:6480464 |
CTD |
| G |
Azin1 |
antizyme inhibitor 1 |
|
increases expression |
ISO |
7 |
74,159,130 |
74,189,447 |
RGD:6480464 |
CTD |
| G |
B3galt6 |
UDP-Gal:betaGal beta 1,3-galactosyltransferase, polypeptide 6 |
|
increases expression |
ISO |
5 |
172,833,647 |
172,835,783 |
RGD:6480464 |
CTD |
| G |
B3gnt1 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 |
|
decreases expression |
ISO |
1 |
207,659,039 |
207,661,261 |
RGD:6480464 |
CTD |
| G |
B3gnt5 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
|
increases expression |
ISO |
11 |
83,396,028 |
83,408,584 |
RGD:6480464 |
CTD |
| G |
B4galnt1 |
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
|
increases expression |
ISO |
7 |
67,120,782 |
67,127,697 |
RGD:6480464 |
CTD |
| G |
B4galt1 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
|
decreases expression |
ISO |
5 |
58,196,388 |
58,243,231 |
RGD:6480464 |
CTD |
| G |
B4galt3 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 3 |
|
increases expression |
ISO |
13 |
87,164,387 |
87,170,376 |
RGD:6480464 |
CTD |
| G |
B4galt7 |
xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 |
|
increases expression |
ISO |
17 |
15,059,958 |
15,068,556 |
RGD:6480464 |
CTD |
| G |
B9d1 |
B9 protein domain 1 |
|
increases expression |
ISO |
10 |
47,665,630 |
47,673,227 |
RGD:6480464 |
CTD |
| G |
Bace1 |
beta-site APP cleaving enzyme 1 |
|
decreases expression |
ISO |
8 |
48,817,824 |
48,839,681 |
RGD:6480464 |
CTD |
| G |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
|
increases expression |
ISO |
11 |
27,467,207 |
27,500,173 |
RGD:6480464 |
CTD |
| G |
Btaf1 |
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, (Mot1 homolog, S. cerevisiae) |
|
increases expression |
ISO |
1 |
241,212,431 |
241,287,889 |
RGD:6480464 |
CTD |
| G |
Btbd10 |
BTB (POZ) domain containing 10 |
|
increases expression |
ISO |
1 |
171,163,519 |
171,221,252 |
RGD:6480464 |
CTD |
| G |
Btc |
betacellulin |
|
increases expression |
ISO |
14 |
18,194,470 |
18,235,228 |
RGD:6480464 |
CTD |
| G |
Btd |
biotinidase |
|
decreases expression |
ISO |
16 |
7,111,351 |
7,141,809 |
RGD:6480464 |
CTD |
| G |
Btf3l4 |
basic transcription factor 3-like 4 |
|
increases expression |
ISO |
5 |
130,123,334 |
130,142,207 |
RGD:6480464 |
CTD |
| G |
Btg3 |
BTG family, member 3 |
|
increases expression |
ISO |
11 |
17,241,627 |
17,257,740 |
RGD:6480464 |
CTD |
| G |
Btnl7 |
butyrophilin-like 7 |
|
increases expression |
ISO |
20 |
4,437,293 |
4,447,525 |
RGD:6480464 |
CTD |
| G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
|
decreases expression |
ISO |
3 |
115,323,510 |
115,354,906 |
RGD:6480464 |
CTD |
| G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
|
decreases expression |
ISO |
3 |
115,323,510 |
115,354,906 |
RGD:6480464 |
CTD |
| G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
decreases expression |
ISO |
3 |
105,063,018 |
105,116,145 |
RGD:6480464 |
CTD |
| G |
Bud31 |
BUD31 homolog (S. cerevisiae) |
|
increases expression |
ISO |
12 |
9,776,932 |
9,784,337 |
RGD:6480464 |
CTD |
| G |
Bysl |
bystin-like |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
C1galt1c1 |
C1GALT1-specific chaperone 1 |
|
decreases expression |
ISO |
X |
6,744,670 |
6,749,116 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
decreases expression |
ISO |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Cachd1 |
cache domain containing 1 |
|
decreases expression |
ISO |
5 |
121,431,272 |
121,659,471 |
RGD:6480464 |
CTD |
| G |
Cacnb2 |
calcium channel, voltage-dependent, beta 2 subunit |
|
decreases expression |
ISO |
17 |
88,832,905 |
89,078,870 |
RGD:6480464 |
CTD |
| G |
Cacybp |
calcyclin binding protein |
|
increases expression |
ISO |
13 |
75,623,161 |
75,633,644 |
RGD:6480464 |
CTD |
| G |
Cadm1 |
cell adhesion molecule 1 |
|
decreases expression |
ISO |
8 |
50,765,645 |
51,108,962 |
RGD:6480464 |
CTD |
| G |
Cadm2 |
cell adhesion molecule 2 |
|
increases expression |
ISO |
11 |
4,273,771 |
5,330,393 |
RGD:6480464 |
CTD |
| G |
Cadps2 |
Ca++-dependent secretion activator 2 |
|
increases expression |
ISO |
4 |
49,658,535 |
50,206,014 |
RGD:6480464 |
CTD |
| G |
Calb2 |
calbindin 2 |
|
increases expression |
ISO |
19 |
40,023,072 |
40,051,150 |
RGD:6480464 |
CTD |
| G |
Calcrl |
calcitonin receptor-like |
|
decreases expression |
ISO |
3 |
67,553,022 |
67,646,877 |
RGD:6480464 |
CTD |
| G |
Calm3 |
calmodulin 3 |
|
decreases expression |
ISO |
1 |
77,245,609 |
77,252,717 |
RGD:6480464 |
CTD |
| G |
Calml4 |
calmodulin-like 4 |
|
decreases expression |
ISO |
8 |
67,007,122 |
67,018,886 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
increases expression |
EXP |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
|
multiple interactions |
EXP |
18 |
56,879,247 |
56,948,537 |
RGD:6480464 |
CTD |
| G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
|
decreases expression |
ISO |
5 |
157,235,534 |
157,237,314 |
RGD:6480464 |
CTD |
| G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
|
multiple interactions |
EXP |
18 |
25,404,123 |
25,625,785 |
RGD:6480464 |
CTD |
| G |
Camlg |
calcium modulating ligand |
|
increases expression |
ISO |
17 |
15,033,873 |
15,044,699 |
RGD:6480464 |
CTD |
| G |
Camsap1 |
calmodulin regulated spectrin-associated protein 1 |
|
increases expression |
ISO |
3 |
4,098,538 |
4,159,591 |
RGD:6480464 |
CTD |
| G |
Camsap2 |
calmodulin regulated spectrin-associated protein family, member 2 |
|
increases expression |
ISO |
13 |
49,309,232 |
49,388,931 |
RGD:6480464 |
CTD |
| G |
Camta2 |
calmodulin binding transcription activator 2 |
|
increases expression |
ISO |
10 |
57,549,855 |
57,567,958 |
RGD:6480464 |
CTD |
| G |
Canx |
calnexin |
|
increases expression |
ISO |
10 |
35,850,944 |
35,883,494 |
RGD:6480464 |
CTD |
| G |
Canx |
calnexin |
|
increases expression |
EXP |
10 |
35,850,944 |
35,883,494 |
RGD:6480464 |
CTD |
| G |
Capn1 |
calpain 1, (mu/I) large subunit |
|
decreases expression |
ISO |
1 |
208,620,286 |
208,645,007 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2, (m/II) large subunit |
|
increases expression |
ISO |
13 |
98,473,367 |
98,524,463 |
RGD:6480464 |
CTD |
| G |
Capn7 |
calpain 7 |
|
increases expression |
ISO |
16 |
6,784,270 |
6,820,953 |
RGD:6480464 |
CTD |
| G |
Car12 |
carbonic anyhydrase 12 |
|
increases expression |
ISO |
8 |
71,017,732 |
71,070,729 |
RGD:6480464 |
CTD |
| G |
Car13 |
carbonic anhydrase 13 |
|
increases expression |
ISO |
2 |
88,271,908 |
88,309,336 |
RGD:6480464 |
CTD |
| G |
Car8 |
carbonic anhydrase 8 |
|
increases expression |
ISO |
5 |
21,951,255 |
22,049,427 |
RGD:6480464 |
CTD |
| G |
Car9 |
carbonic anhydrase 9 |
|
decreases expression |
ISO |
5 |
59,986,413 |
59,993,015 |
RGD:6480464 |
CTD |
| G |
Card10 |
caspase recruitment domain family, member 10 |
|
decreases expression |
ISO |
7 |
116,737,928 |
116,766,959 |
RGD:6480464 |
CTD |
| G |
Card6 |
caspase recruitment domain family, member 6 |
|
decreases expression |
ISO |
2 |
54,282,217 |
54,293,630 |
RGD:6480464 |
CTD |
| G |
Cars |
cysteinyl-tRNA synthetase |
|
increases expression |
ISO |
1 |
203,934,812 |
203,977,042 |
RGD:6480464 |
CTD |
| G |
Cask |
calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
|
increases expression |
ISO |
X |
20,910,960 |
21,250,869 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
decreases expression |
ISO |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Ccdc176 |
coiled-coil domain containing 176 |
|
increases expression |
ISO |
6 |
108,473,030 |
108,498,836 |
RGD:6480464 |
CTD |
| G |
Ccdc178 |
coiled-coil domain containing 178 |
|
increases expression |
ISO |
18 |
13,440,195 |
13,817,915 |
RGD:6480464 |
CTD |
| G |
Ccl27 |
chemokine (C-C motif) ligand 27 |
|
decreases expression |
ISO |
5 |
59,199,779 |
59,204,297 |
RGD:6480464 |
CTD |
| G |
Cct4 |
chaperonin containing Tcp1, subunit 4 (delta) |
|
increases expression |
ISO |
14 |
103,675,110 |
103,687,893 |
RGD:6480464 |
CTD |
| G |
Cct5 |
chaperonin containing Tcp1, subunit 5 (epsilon) |
|
increases expression |
ISO |
2 |
83,681,785 |
83,692,937 |
RGD:6480464 |
CTD |
| G |
Cct6a |
chaperonin containing Tcp1, subunit 6A (zeta 1) |
|
increases expression |
ISO |
12 |
27,992,348 |
28,002,578 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
decreases expression |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd1d1 |
CD1d1 molecule |
|
decreases expression |
ISO |
2 |
179,011,165 |
179,014,672 |
RGD:6480464 |
CTD |
| G |
Cd302 |
CD302 molecule |
|
decreases expression |
ISO |
3 |
41,958,036 |
41,991,705 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
increases expression |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd55 |
Cd55 molecule |
|
increases expression |
ISO |
13 |
43,322,246 |
43,348,334 |
RGD:6480464 |
CTD |
| G |
Cd59 |
CD59 molecule, complement regulatory protein |
|
decreases expression |
ISO |
3 |
89,243,600 |
89,245,129 |
RGD:6480464 |
CTD |
| G |
Cd63 |
Cd63 molecule |
|
increases expression |
ISO |
7 |
2,208,659 |
2,211,323 |
RGD:6480464 |
CTD |
| G |
Cd68 |
Cd68 molecule |
|
decreases expression |
ISO |
10 |
56,481,701 |
56,483,580 |
RGD:6480464 |
CTD |
| G |
Cd81 |
Cd81 molecule |
|
decreases expression |
ISO |
1 |
203,327,287 |
203,342,901 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 molecule |
|
increases expression |
ISO |
4 |
162,279,462 |
162,312,889 |
RGD:6480464 |
CTD |
| G |
Cda |
cytidine deaminase |
|
affects expression |
ISO |
5 |
157,117,303 |
157,143,989 |
RGD:6480464 |
CTD |
| G |
Cdc16 |
cell division cycle 16 |
|
increases expression |
ISO |
16 |
80,628,131 |
80,650,925 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
decreases expression |
ISO |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc25a |
cell division cycle 25A |
|
decreases expression |
ISO |
8 |
114,237,704 |
114,255,971 |
RGD:6480464 |
CTD |
| G |
Cdc25b |
cell division cycle 25B |
|
decreases expression |
ISO |
3 |
118,893,716 |
118,903,516 |
RGD:6480464 |
CTD |
| G |
Cdc27 |
cell division cycle 27 |
|
increases expression |
ISO |
10 |
93,678,790 |
93,725,987 |
RGD:6480464 |
CTD |
| G |
Cdc42ep4 |
CDC42 effector protein (Rho GTPase binding) 4 |
|
decreases expression |
ISO |
10 |
103,365,895 |
103,390,663 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
increases expression |
ISO |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdc7 |
cell division cycle 7 |
|
decreases expression |
ISO |
14 |
3,421,621 |
3,441,738 |
RGD:6480464 |
CTD |
| G |
Cdca2 |
cell division cycle associated 2 |
|
decreases expression |
ISO |
15 |
47,225,711 |
47,271,412 |
RGD:6480464 |
CTD |
| G |
Cdca3 |
cell division cycle associated 3 |
|
decreases expression |
ISO |
4 |
160,952,986 |
160,956,574 |
RGD:6480464 |
CTD |
| G |
Cdca4 |
cell division cycle associated 4 |
|
increases expression |
ISO |
6 |
137,818,816 |
137,828,119 |
RGD:6480464 |
CTD |
| G |
Cdca7 |
cell division cycle associated 7 |
|
decreases expression |
ISO |
3 |
54,948,493 |
54,959,128 |
RGD:6480464 |
CTD |
| G |
Cdca7l |
cell division cycle associated 7 like |
|
increases expression |
ISO |
6 |
145,146,073 |
145,191,663 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
decreases expression |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh10 |
cadherin 10 |
|
increases expression |
ISO |
2 |
69,472,301 |
69,696,553 |
RGD:6480464 |
CTD |
| G |
Cdh12 |
cadherin 12 |
|
decreases expression |
ISO |
2 |
72,175,690 |
72,598,944 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
decreases expression |
ISO |
18 |
8,048,920 |
8,267,974 |
RGD:6480464 |
CTD |
| G |
Cdhr2 |
cadherin-related family member 2 |
|
decreases expression |
ISO |
17 |
15,937,987 |
15,962,796 |
RGD:6480464 |
CTD |
| G |
Cdipt |
CDP-diacylglycerol--inositol 3-phosphatidyltransferase |
|
decreases expression |
ISO |
1 |
186,153,278 |
186,157,415 |
RGD:6480464 |
CTD |
| G |
Cdk18 |
cyclin-dependent kinase 18 |
|
decreases expression |
ISO |
13 |
44,996,447 |
45,004,813 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases expression |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2ap2 |
cyclin-dependent kinase 2 associated protein 2 |
|
increases expression |
ISO |
1 |
206,681,430 |
206,683,098 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk5 |
cyclin-dependent kinase 5 |
|
decreases expression |
ISO |
4 |
6,119,704 |
6,124,186 |
RGD:6480464 |
CTD |
| G |
Cdk5rap2 |
CDK5 regulatory subunit associated protein 2 |
|
increases expression |
ISO |
5 |
87,564,010 |
87,738,257 |
RGD:6480464 |
CTD |
| G |
Cdk7 |
cyclin-dependent kinase 7 |
|
increases expression |
ISO |
2 |
31,500,629 |
31,525,590 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn2aip |
CDKN2A interacting protein |
|
increases expression |
ISO |
16 |
47,746,221 |
47,749,499 |
RGD:6480464 |
CTD |
| G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
decreases expression |
ISO |
5 |
131,012,524 |
131,017,679 |
RGD:6480464 |
CTD |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
affects expression |
ISO |
15 |
22,617,409 |
22,624,922 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase, type I |
|
decreases expression |
ISO |
18 |
40,914,028 |
40,928,671 |
RGD:6480464 |
CTD |
| G |
Cdr2 |
cerebellar degeneration-related 2 |
|
decreases expression |
ISO |
1 |
179,804,350 |
179,829,258 |
RGD:6480464 |
CTD |
| G |
Cdr2 |
cerebellar degeneration-related 2 |
|
increases expression |
ISO |
1 |
179,804,350 |
179,829,258 |
RGD:6480464 |
CTD |
| G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
|
decreases expression |
ISO |
19 |
52,848,559 |
52,853,880 |
RGD:6480464 |
CTD |
| G |
Cdv3 |
carnitine deficiency-associated gene expressed in ventricle 3 homolog (mouse) |
|
increases expression |
ISO |
8 |
108,365,896 |
108,376,263 |
RGD:6480464 |
CTD |
| G |
Cdyl |
chromodomain protein, Y-like |
|
increases expression |
ISO |
17 |
35,290,255 |
35,517,646 |
RGD:6480464 |
CTD |
| G |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
|
decreases expression |
ISO |
1 |
80,742,540 |
80,758,943 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpg |
CCAAT/enhancer binding protein (C/EBP), gamma |
|
increases expression |
ISO |
1 |
87,552,695 |
87,559,447 |
RGD:6480464 |
CTD |
| G |
Cebpz |
CCAAT/enhancer binding protein zeta |
|
increases expression |
ISO |
6 |
1,698,162 |
1,715,846 |
RGD:6480464 |
CTD |
| G |
Celf1 |
CUGBP, Elav-like family member 1 |
|
decreases expression |
ISO |
3 |
75,360,927 |
75,378,582 |
RGD:6480464 |
CTD |
| G |
Celf6 |
CUGBP, Elav-like family member 6 |
|
increases expression |
ISO |
8 |
63,401,862 |
63,433,540 |
RGD:6480464 |
CTD |
| G |
Clcn5 |
chloride channel, voltage-sensitive 5 |
|
decreases expression |
ISO |
X |
27,383,769 |
27,409,877 |
RGD:6480464 |
CTD |
| G |
Clcn7 |
chloride channel, voltage-sensitive 7 |
|
increases expression |
ISO |
10 |
14,379,803 |
14,403,898 |
RGD:6480464 |
CTD |
| G |
Cldn14 |
claudin 14 |
|
decreases expression |
ISO |
11 |
34,142,138 |
34,151,928 |
RGD:6480464 |
CTD |
| G |
Cldn3 |
claudin 3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Clgn |
calmegin |
|
increases expression |
ISO |
19 |
26,404,126 |
26,436,081 |
RGD:6480464 |
CTD |
| G |
Clic1 |
chloride intracellular channel 1 |
|
increases expression |
ISO |
20 |
3,498,935 |
3,842,500 |
RGD:6480464 |
CTD |
| G |
Clic2 |
chloride intracellular channel 2 |
|
increases expression |
ISO |
20 |
66,518 |
81,543 |
RGD:6480464 |
CTD |
| G |
Clic4 |
chloride intracellular channel 4 |
|
increases expression |
ISO |
5 |
154,005,244 |
154,066,883 |
RGD:6480464 |
CTD |
| G |
Clint1 |
clathrin interactor 1 |
|
increases expression |
ISO |
10 |
30,996,087 |
31,047,175 |
RGD:6480464 |
CTD |
| G |
Clip1 |
CAP-GLY domain containing linker protein 1 |
|
increases expression |
ISO |
12 |
34,049,773 |
34,155,531 |
RGD:6480464 |
CTD |
| G |
Clip2 |
CAP-GLY domain containing linker protein 2 |
|
increases expression |
ISO |
12 |
23,228,309 |
23,292,105 |
RGD:6480464 |
CTD |
| G |
Clip4 |
CAP-GLY domain containing linker protein family, member 4 |
|
increases expression |
ISO |
6 |
23,749,168 |
23,832,427 |
RGD:6480464 |
CTD |
| G |
Clk1 |
CDC-like kinase 1 |
|
increases expression |
ISO |
9 |
57,070,825 |
57,082,043 |
RGD:6480464 |
CTD |
| G |
Cln3 |
ceroid-lipofuscinosis, neuronal 3 |
|
decreases expression |
ISO |
1 |
185,713,096 |
185,724,375 |
RGD:6480464 |
CTD |
| G |
Cln5 |
ceroid-lipofuscinosis, neuronal 5 |
|
decreases expression |
ISO |
15 |
87,080,071 |
87,089,784 |
RGD:6480464 |
CTD |
| G |
Cln8 |
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) |
|
increases expression |
ISO |
16 |
79,569,745 |
79,579,636 |
RGD:6480464 |
CTD |
| G |
Clrn3 |
clarin 3 |
|
decreases expression |
ISO |
1 |
195,132,680 |
195,148,303 |
RGD:6480464 |
CTD |
| G |
Clybl |
citrate lyase beta like |
|
decreases expression |
ISO |
15 |
107,313,924 |
107,539,458 |
RGD:6480464 |
CTD |
| G |
Cmbl |
carboxymethylenebutenolidase homolog (Pseudomonas) |
|
decreases expression |
ISO |
2 |
83,659,292 |
83,681,042 |
RGD:6480464 |
CTD |
| G |
Cmpk2 |
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
|
decreases expression |
ISO |
6 |
44,128,544 |
44,139,346 |
RGD:6480464 |
CTD |
| G |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
|
decreases expression |
ISO |
8 |
119,149,810 |
119,165,515 |
RGD:6480464 |
CTD |
| G |
Cndp2 |
CNDP dipeptidase 2 (metallopeptidase M20 family) |
|
increases expression |
ISO |
18 |
81,215,851 |
81,232,949 |
RGD:6480464 |
CTD |
| G |
Cnga1 |
cyclic nucleotide gated channel alpha 1 |
|
decreases expression |
ISO |
14 |
38,017,762 |
38,033,098 |
RGD:6480464 |
CTD |
| G |
Cnih4 |
cornichon homolog 4 (Drosophila) |
|
increases expression |
ISO |
13 |
96,921,481 |
96,940,409 |
RGD:6480464 |
CTD |
| G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
|
decreases expression |
ISO |
1 |
243,859,015 |
243,896,003 |
RGD:6480464 |
CTD |
| G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
|
decreases expression |
ISO |
1 |
243,859,015 |
243,896,003 |
RGD:6480464 |
CTD |
| G |
Eif1 |
eukaryotic translation initiation factor 1 |
|
increases expression |
ISO |
10 |
89,255,637 |
89,257,728 |
RGD:6480464 |
CTD |
| G |
Fam213a |
family with sequence similarity 213, member A |
|
decreases expression |
ISO |
16 |
17,425,527 |
17,445,308 |
RGD:6480464 |
CTD |
| G |
Fam219a |
family with sequence similarity 219, member A |
|
increases expression |
ISO |
5 |
58,939,482 |
58,988,651 |
RGD:6480464 |
CTD |
| G |
Fuom |
fucose mutarotase |
|
decreases expression |
ISO |
1 |
199,895,086 |
199,899,596 |
RGD:6480464 |
CTD |
| G |
Fzd7 |
frizzled family receptor 7 |
|
increases expression |
ISO |
9 |
58,063,740 |
58,066,559 |
RGD:6480464 |
CTD |
| G |
Hid1 |
HID1 domain containing |
|
increases expression |
ISO |
10 |
105,424,827 |
105,445,183 |
RGD:6480464 |
CTD |
| G |
Idnk |
idnK, gluconokinase homolog (E. coli) |
|
decreases expression |
ISO |
17 |
12,427,114 |
12,433,831 |
RGD:6480464 |
CTD |
| G |
Idua |
iduronidase, alpha-L- |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
l7Rn6 |
lethal, Chr 7, Rinchik 6 |
|
increases expression |
ISO |
1 |
146,522,014 |
146,545,388 |
RGD:6480464 |
CTD |
| G |
Ldlrad4 |
low density lipoprotein receptor class A domain containing 4 |
|
decreases expression |
ISO |
18 |
64,755,404 |
64,788,816 |
RGD:6480464 |
CTD |
| G |
LOC361635 |
similar to RIKEN cDNA 9030624J02 |
|
decreases expression |
ISO |
1 |
176,965,214 |
177,069,399 |
RGD:6480464 |
CTD |
| G |
LOC498685 |
similar to UPF0308 protein C9orf21 |
|
increases expression |
ISO |
17 |
6,336,052 |
6,370,548 |
RGD:6480464 |
CTD |
| G |
LOC500300 |
similar to hypothetical protein MGC6835 |
|
affects expression |
ISO |
4 |
153,000,782 |
153,002,562 |
RGD:6480464 |
CTD |
| G |
LOC501282 |
similar to lymphocyte antigen 6 complex, locus E ligand |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
LOC502894 |
hypothetical protein LOC502894 |
|
increases expression |
ISO |
4 |
163,481,393 |
163,502,412 |
RGD:6480464 |
CTD |
| G |
LOC679576 |
hypothetical protein LOC679576 |
|
increases expression |
ISO |
10 |
59,107,710 |
59,108,313 |
RGD:6480464 |
CTD |
| G |
LOC680191 |
similar to UPF0197 protein C11orf10 homolog |
|
increases expression |
ISO |
X |
123,375,265 |
123,375,562 |
RGD:6480464 |
CTD |
| G |
LOC689959 |
hypothetical protein LOC689959 |
|
decreases expression |
ISO |
8 |
54,093,696 |
54,100,678 |
RGD:6480464 |
CTD |
| G |
LOC690000 |
similar to CG3740-PA |
|
decreases expression |
ISO |
1 |
90,662,111 |
90,674,684 |
RGD:6480464 |
CTD |
| G |
LOC691138 |
hypothetical protein LOC691138 |
|
increases expression |
ISO |
4 |
179,975,336 |
179,980,842 |
RGD:6480464 |
CTD |
| G |
LOC691427 |
similar to 6.8 kDa mitochondrial proteolipid |
|
decreases expression |
ISO |
6 |
136,747,827 |
136,753,571 |
RGD:6480464 |
CTD |
| G |
MGC94282 |
similar to 5930416I19Rik protein |
|
increases expression |
ISO |
4 |
165,378,057 |
165,383,443 |
RGD:6480464 |
CTD |
| G |
Mlxipl |
MLX interacting protein-like |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Msantd3 |
Myb/SANT-like DNA-binding domain containing 3 |
|
increases expression |
ISO |
5 |
65,226,927 |
65,249,757 |
RGD:6480464 |
CTD |
| G |
Ndufb1 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ndufb3 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3 |
|
decreases expression |
ISO |
9 |
57,252,769 |
57,262,981 |
RGD:6480464 |
CTD |
| G |
Neurl1a |
neuralized homolog 1A (Drosophila) |
|
increases expression |
ISO |
1 |
252,502,664 |
252,573,249 |
RGD:6480464 |
CTD |
| G |
Nmrk1 |
nicotinamide riboside kinase 1 |
|
increases expression |
ISO |
1 |
222,230,110 |
222,257,462 |
RGD:6480464 |
CTD |
| G |
Npepo |
aminopeptidase O |
|
decreases expression |
ISO |
17 |
7,353,426 |
7,624,936 |
RGD:6480464 |
CTD |
| G |
RGD1304595 |
similar to RIKEN cDNA 6330416G13 gene |
|
increases expression |
ISO |
5 |
80,531,483 |
80,555,551 |
RGD:6480464 |
CTD |
| G |
RGD1304704 |
similar to Hypothetical protein CGI-99 |
|
increases expression |
ISO |
15 |
4,790,458 |
4,800,905 |
RGD:6480464 |
CTD |
| G |
RGD1305420 |
similar to Nef associated protein 1 |
|
increases expression |
ISO |
5 |
62,943,064 |
62,951,845 |
RGD:6480464 |
CTD |
| G |
RGD1307621 |
hypothetical LOC314168 |
|
increases expression |
ISO |
6 |
86,256,155 |
86,263,086 |
RGD:6480464 |
CTD |
| G |
RGD1308117 |
similar to 9930012K11Rik protein |
|
decreases expression |
ISO |
15 |
50,555,250 |
50,559,887 |
RGD:6480464 |
CTD |
| G |
RGD1309534 |
similar to RIKEN cDNA 4931406C07 |
|
decreases expression |
ISO |
8 |
12,084,956 |
12,106,942 |
RGD:6480464 |
CTD |
| G |
RGD1309748 |
similar to CG4768-PA |
|
increases expression |
ISO |
10 |
6,781,181 |
6,810,122 |
RGD:6480464 |
CTD |
| G |
RGD1310769 |
similar to HSPC288 |
|
decreases expression |
ISO |
6 |
109,934,787 |
109,945,923 |
RGD:6480464 |
CTD |
| G |
RGD1310852 |
similar to RIKEN cDNA 9130401M01 |
|
increases expression |
ISO |
7 |
94,729,977 |
94,740,627 |
RGD:6480464 |
CTD |
| G |
RGD1311164 |
similar to DNA segment, Chr 6, Wayne State University 163, expressed |
|
increases expression |
ISO |
4 |
163,322,116 |
163,355,524 |
RGD:6480464 |
CTD |
| G |
RGD1311805 |
similar to RIKEN cDNA 2400010D15 |
|
increases expression |
ISO |
18 |
3,705,351 |
3,725,697 |
RGD:6480464 |
CTD |
| G |
RGD1359108 |
similar to RIKEN cDNA 3110043O21 |
|
increases expression |
ISO |
5 |
51,839,724 |
51,865,205 |
RGD:6480464 |
CTD |
| G |
RGD1359158 |
similar to RIKEN cDNA 1110059E24 |
|
increases expression |
ISO |
1 |
224,820,924 |
224,887,275 |
RGD:6480464 |
CTD |
| G |
RGD1359310 |
similar to RIKEN cDNA 9430023L20 |
|
increases expression |
ISO |
7 |
140,029,813 |
140,038,925 |
RGD:6480464 |
CTD |
| G |
RGD1560108 |
similar to RIKEN cDNA 2700081O15 |
|
decreases expression |
ISO |
1 |
210,104,665 |
210,109,541 |
RGD:6480464 |
CTD |
| G |
RGD1560436 |
similar to hypothetical protein FLJ20508 |
|
increases expression |
ISO |
5 |
144,276,540 |
144,281,846 |
RGD:6480464 |
CTD |
| G |
RGD1562310 |
similar to hypothetical protein FLJ21415 |
|
increases expression |
ISO |
12 |
39,441,308 |
39,461,715 |
RGD:6480464 |
CTD |
| G |
RGD1563325 |
similar to hypothetical protein MGC17943 |
|
increases expression |
ISO |
7 |
20,722,309 |
20,742,528 |
RGD:6480464 |
CTD |
| G |
RGD1565536 |
similar to hypothetical protein |
|
increases expression |
ISO |
3 |
105,260,699 |
105,266,052 |
RGD:6480464 |
CTD |
| G |
RGD621098 |
similar to RIKEN cDNA D230025D16Rik |
|
decreases expression |
ISO |
19 |
35,038,531 |
35,066,395 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor A |
|
decreases expression |
ISO |
8 |
73,052,282 |
73,817,764 |
RGD:6480464 |
CTD |
| G |
Rpp25l |
ribonuclease P/MRP 25 subunit-like |
|
decreases expression |
ISO |
5 |
59,136,895 |
59,138,295 |
RGD:6480464 |
CTD |
| G |
Smco4 |
single-pass membrane protein with coiled-coil domains 4 |
|
increases expression |
ISO |
8 |
12,328,341 |
12,347,919 |
RGD:6480464 |
CTD |
| G |
Taf15 |
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
decreases expression |
ISO |
10 |
71,555,890 |
71,587,919 |
RGD:6480464 |
CTD |
| G |
Them6 |
thioesterase superfamily member 6 |
|
decreases expression |
ISO |
7 |
112,835,301 |
112,838,479 |
RGD:6480464 |
CTD |
| G |
Tmem256 |
transmembrane protein 256 |
|
decreases expression |
ISO |
10 |
56,678,860 |
56,680,351 |
RGD:6480464 |
CTD |
| G |
Trim6 |
tripartite motif containing 6 |
|
decreases expression |
ISO |
1 |
162,059,220 |
162,094,672 |
RGD:6480464 |
CTD |
| G |
Usb1 |
U6 snRNA biogenesis 1 |
|
decreases expression |
ISO |
19 |
10,148,223 |
10,162,086 |
RGD:6480464 |
CTD |
| G |
Wbp1l |
WW domain binding protein 1-like |
|
decreases expression |
ISO |
1 |
251,901,560 |
251,958,599 |
RGD:6480464 |
CTD |
desmopressin
|
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
increases expression |
ISO |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
multiple interactions |
ISO |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
increases expression |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Aqp2 |
aquaporin 2 (collecting duct) |
|
multiple interactions |
EXP |
7 |
138,325,855 |
138,330,891 |
RGD:6480464 |
CTD |
| G |
Avpr2 |
arginine vasopressin receptor 2 |
|
multiple interactions |
EXP |
X |
159,821,860 |
159,823,488 |
RGD:6480464 |
CTD |
| G |
Avpr2 |
arginine vasopressin receptor 2 |
|
multiple interactions |
ISO |
X |
159,821,860 |
159,823,488 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
increases activity |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Myl9 |
myosin, light chain 9, regulatory |
|
increases phosphorylation |
EXP |
3 |
147,190,252 |
147,193,865 |
RGD:6480464 |
CTD |
| G |
Myl9 |
myosin, light chain 9, regulatory |
|
multiple interactions |
EXP |
3 |
147,190,252 |
147,193,865 |
RGD:6480464 |
CTD |
| G |
Scnn1b |
sodium channel, nonvoltage-gated 1, beta |
|
increases expression |
EXP |
1 |
180,682,622 |
180,748,068 |
RGD:6480464 |
CTD |
| G |
Scnn1g |
sodium channel, nonvoltage-gated 1, gamma |
|
increases expression |
EXP |
1 |
180,555,660 |
180,589,534 |
RGD:6480464 |
CTD |
| G |
Vwf |
von Willebrand factor |
|
increases activity |
ISO |
4 |
161,723,415 |
161,854,766 |
RGD:6480464 |
CTD |
| G |
Vwf |
von Willebrand factor |
|
increases secretion |
ISO |
4 |
161,723,415 |
161,854,766 |
RGD:6480464 |
CTD |
| G |
Vwf |
von Willebrand factor |
|
increases secretion |
ISO |
4 |
161,723,415 |
161,854,766 |
RGD:6480464 |
CTD |
fentanyl
|
| G |
Crh |
corticotropin releasing hormone |
|
affects expression |
EXP |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases metabolic processing |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Gast |
gastrin |
|
multiple interactions |
EXP |
10 |
89,273,628 |
89,276,192 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
increases phosphorylation |
ISO |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
increases phosphorylation |
ISO |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Pdyn |
prodynorphin |
|
increases expression |
EXP |
3 |
117,291,025 |
117,303,367 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
decreases expression |
ISO |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
multiple interactions |
ISO |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
multiple interactions |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
metoclopramide
|
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
affects response to substance |
ISO |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Amy1a |
amylase, alpha 1A (salivary) |
|
multiple interactions |
EXP |
2 |
209,548,721 |
209,563,532 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects expression |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases expression |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
multiple interactions |
ISO |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
multiple interactions |
ISO |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Bche |
butyrylcholinesterase |
|
multiple interactions |
ISO |
2 |
164,329,613 |
164,427,994 |
RGD:6480464 |
CTD |
| G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
|
multiple interactions |
EXP |
17 |
71,214,906 |
71,218,463 |
RGD:6480464 |
CTD |
| G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
|
affects binding |
EXP |
17 |
71,214,906 |
71,218,463 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
affects metabolic processing |
ISO |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
affects metabolic processing |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
affects binding |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
affects binding |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
increases expression |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
affects binding |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Gcg |
glucagon |
|
increases secretion |
ISO |
3 |
44,433,180 |
44,438,004 |
RGD:6480464 |
CTD |
| G |
Gip |
gastric inhibitory polypeptide |
|
increases secretion |
ISO |
10 |
84,732,705 |
84,740,801 |
RGD:6480464 |
CTD |
| G |
Htr3a |
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
|
multiple interactions |
ISO |
8 |
52,161,147 |
52,173,514 |
RGD:6480464 |
CTD |
| G |
Htr3a |
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
|
multiple interactions |
ISO |
8 |
52,161,147 |
52,173,514 |
RGD:6480464 |
CTD |
| G |
Htr3a |
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
|
decreases activity |
ISO |
8 |
52,161,147 |
52,173,514 |
RGD:6480464 |
CTD |
| G |
Htr3a |
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
|
multiple interactions |
EXP |
8 |
52,161,147 |
52,173,514 |
RGD:6480464 |
CTD |
| G |
Htr3a |
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
|
affects binding |
EXP |
8 |
52,161,147 |
52,173,514 |
RGD:6480464 |
CTD |
| G |
Htr3a |
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
|
affects binding |
EXP |
8 |
52,161,147 |
52,173,514 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
increases expression |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
decreases activity |
ISO |
4 |
6,192,644 |
6,224,285 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
increases expression |
ISO |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
affects expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prlr |
prolactin receptor |
|
increases expression |
ISO |
2 |
59,507,966 |
59,701,221 |
RGD:6480464 |
CTD |
| G |
Srd5a1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
increases expression |
EXP |
17 |
3,845,190 |
3,879,165 |
RGD:6480464 |
CTD |
| G |
Srd5a2 |
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
|
increases expression |
EXP |
6 |
21,453,521 |
21,489,408 |
RGD:6480464 |
CTD |
microcystin-LR
|
| G |
Abca8 |
ATP-binding cassette, subfamily A (ABC1), member 8 |
|
increases expression |
ISO |
10 |
99,392,053 |
99,452,833 |
RGD:6480464 |
CTD |
| G |
Abcb10 |
ATP-binding cassette, subfamily B (MDR/TAP), member 10 |
|
decreases expression |
ISO |
19 |
54,151,400 |
54,181,495 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc5 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 5 |
|
increases expression |
ISO |
11 |
82,714,334 |
82,809,354 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
decreases expression |
ISO |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Afm |
afamin |
|
decreases expression |
ISO |
14 |
19,049,664 |
19,082,977 |
RGD:6480464 |
CTD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
increases expression |
ISO |
4 |
61,645,438 |
61,659,530 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
decreases expression |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
decreases expression |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
|
increases phosphorylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
increases expression |
ISO |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Anxa4 |
annexin A4 |
|
increases expression |
ISO |
4 |
120,889,617 |
120,947,662 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
increases expression |
ISO |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Anxa7 |
annexin A7 |
|
increases expression |
ISO |
15 |
4,047,956 |
4,075,981 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
increases expression |
ISO |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Arhgef2 |
rho/rac guanine nucleotide exchange factor (GEF) 2 |
|
increases expression |
ISO |
2 |
180,748,313 |
180,775,656 |
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
increases expression |
ISO |
4 |
32,758,866 |
32,776,220 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
decreases expression |
ISO |
3 |
10,578,717 |
10,622,332 |
RGD:6480464 |
CTD |
| G |
Atox1 |
ATX1 antioxidant protein 1 homolog (yeast) |
|
increases expression |
ISO |
10 |
40,858,190 |
40,873,226 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Blvrb |
biliverdin reductase B (flavin reductase (NADPH)) |
|
increases expression |
ISO |
1 |
82,528,943 |
82,546,606 |
RGD:6480464 |
CTD |
| G |
Bsg |
basigin (Ok blood group) |
|
decreases expression |
ISO |
7 |
11,507,914 |
11,515,132 |
RGD:6480464 |
CTD |
| G |
C9 |
complement component 9 |
|
decreases expression |
ISO |
2 |
55,743,084 |
55,791,148 |
RGD:6480464 |
CTD |
| G |
Calm2 |
calmodulin 2 |
|
increases expression |
ISO |
6 |
64,161,641 |
64,162,751 |
RGD:6480464 |
CTD |
| G |
Calm3 |
calmodulin 3 |
|
increases expression |
ISO |
1 |
77,245,609 |
77,252,717 |
RGD:6480464 |
CTD |
| G |
Camk1 |
calcium/calmodulin-dependent protein kinase I |
|
increases expression |
ISO |
4 |
149,220,661 |
149,229,168 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2, (m/II) large subunit |
|
increases expression |
ISO |
13 |
98,473,367 |
98,524,463 |
RGD:6480464 |
CTD |
| G |
Capns1 |
calpain, small subunit 1 |
|
increases expression |
ISO |
1 |
85,519,568 |
85,525,929 |
RGD:6480464 |
CTD |
| G |
Capzb |
capping protein (actin filament) muscle Z-line, beta |
|
increases expression |
ISO |
5 |
157,980,877 |
158,080,682 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cast |
calpastatin |
|
increases expression |
ISO |
2 |
1,495,048 |
1,608,477 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cbr1 |
carbonyl reductase 1 |
|
increases expression |
ISO |
11 |
33,787,957 |
33,790,320 |
RGD:6480464 |
CTD |
| G |
Cbr3 |
carbonyl reductase 3 |
|
increases expression |
ISO |
11 |
33,913,961 |
33,922,221 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
decreases expression |
ISO |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
ISO |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Cd2ap |
CD2-associated protein |
|
increases expression |
ISO |
9 |
13,827,015 |
13,888,338 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
increases expression |
ISO |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Coro1c |
coronin, actin binding protein 1C |
|
increases expression |
ISO |
12 |
43,747,188 |
43,819,356 |
RGD:6480464 |
CTD |
| G |
Creb3 |
cAMP responsive element binding protein 3 |
|
increases expression |
ISO |
5 |
60,040,874 |
60,045,512 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Cstb |
cystatin B (stefin B) |
|
increases expression |
ISO |
20 |
10,576,664 |
10,578,706 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases ubiquitination |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
ISO |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Ctsz |
cathepsin Z |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cttn |
cortactin |
|
increases expression |
ISO |
1 |
204,865,768 |
204,901,221 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
increases expression |
ISO |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp8b1 |
cytochrome P450, family 8, subfamily b, polypeptide 1 |
|
decreases expression |
ISO |
8 |
127,018,908 |
127,020,878 |
RGD:6480464 |
CTD |
| G |
Dap3 |
death associated protein 3 |
|
increases expression |
ISO |
2 |
180,987,242 |
181,014,360 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
affects expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
increases expression |
ISO |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
|
increases expression |
ISO |
2 |
51,881,101 |
51,881,461 |
RGD:6480464 |
CTD |
| G |
Decr2 |
2,4-dienoyl CoA reductase 2, peroxisomal |
|
decreases expression |
ISO |
10 |
15,350,593 |
15,358,640 |
RGD:6480464 |
CTD |
| G |
Dusp10 |
dual specificity phosphatase 10 |
|
increases expression |
ISO |
13 |
100,022,421 |
100,059,539 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Ftl |
ferritin, light polypeptide |
|
decreases expression |
ISO |
1 |
95,929,248 |
95,931,092 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
decreases expression |
ISO |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
|
decreases expression |
ISO |
17 |
19,230,896 |
19,232,641 |
RGD:6480464 |
CTD |
| G |
Gck |
glucokinase |
|
increases expression |
ISO |
14 |
86,572,518 |
86,587,723 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
|
increases expression |
ISO |
2 |
250,704,151 |
250,733,988 |
RGD:6480464 |
CTD |
| G |
Glrx3 |
glutaredoxin 3 |
|
increases expression |
ISO |
1 |
197,176,020 |
197,206,249 |
RGD:6480464 |
CTD |
| G |
Gna13 |
guanine nucleotide binding protein (G protein), alpha 13 |
|
increases expression |
ISO |
10 |
98,933,205 |
98,965,819 |
RGD:6480464 |
CTD |
| G |
Gnb1 |
guanine nucleotide binding protein (G protein), beta polypeptide 1 |
|
increases expression |
ISO |
5 |
172,341,135 |
172,386,772 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
increases expression |
ISO |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
increases expression |
ISO |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
increases expression |
ISO |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsn |
gelsolin |
|
increases expression |
ISO |
3 |
14,360,245 |
14,386,313 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
increases expression |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
increases expression |
ISO |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
multiple interactions |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
ISO |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
decreases expression |
ISO |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
multiple interactions |
ISO |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
increases expression |
ISO |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gstk1 |
glutathione S-transferase kappa 1 |
|
decreases expression |
ISO |
4 |
69,999,767 |
70,004,086 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
decreases expression |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
multiple interactions |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
increases expression |
ISO |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
increases expression |
ISO |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gstm4 |
glutathione S-transferase mu 4 |
|
increases expression |
ISO |
2 |
203,605,593 |
203,610,817 |
RGD:6480464 |
CTD |
| G |
Gstm6 |
glutathione S-transferase, mu 6 |
|
decreases expression |
ISO |
2 |
203,504,228 |
203,509,002 |
RGD:6480464 |
CTD |
| G |
Gstm6 |
glutathione S-transferase, mu 6 |
|
increases expression |
ISO |
2 |
203,504,228 |
203,509,002 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
multiple interactions |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Hk2 |
hexokinase 2 |
|
increases expression |
ISO |
4 |
116,925,725 |
116,975,211 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
increases expression |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases phosphorylation |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
|
decreases expression |
ISO |
9 |
63,769,401 |
63,790,622 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
decreases expression |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
increases expression |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Jak1 |
Janus kinase 1 |
|
increases expression |
ISO |
5 |
121,804,586 |
121,905,581 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jund |
jun D proto-oncogene |
|
increases expression |
ISO |
16 |
19,239,694 |
19,241,529 |
RGD:6480464 |
CTD |
| G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
affects binding |
ISO |
8 |
20,259,178 |
20,266,351 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
increases phosphorylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
increases expression |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
multiple interactions |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Lgals1 |
lectin, galactoside-binding, soluble, 1 |
|
increases expression |
ISO |
7 |
116,893,662 |
116,896,768 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
ISO |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lgals3bp |
lectin, galactoside-binding, soluble, 3 binding protein |
|
increases expression |
ISO |
10 |
108,388,185 |
108,397,523 |
RGD:6480464 |
CTD |
| G |
Lpin2 |
lipin 2 |
|
decreases expression |
ISO |
9 |
110,380,692 |
110,484,329 |
RGD:6480464 |
CTD |
| G |
Map3k1 |
mitogen activated protein kinase kinase kinase 1 |
|
increases expression |
ISO |
2 |
43,062,252 |
43,126,058 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
EXP |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
increases phosphorylation |
EXP |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases expression |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
increases expression |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
affects phosphorylation |
ISO |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
increases phosphorylation |
EXP |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
increases localization |
EXP |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
multiple interactions |
EXP |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mfge8 |
milk fat globule-EGF factor 8 protein |
|
increases expression |
ISO |
1 |
134,870,029 |
134,885,431 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Msrb1 |
methionine sulfoxide reductase B1 |
|
decreases expression |
ISO |
10 |
13,992,929 |
13,998,642 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
decreases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Net1 |
neuroepithelial cell transforming 1 |
|
increases expression |
ISO |
17 |
77,533,225 |
77,543,337 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
decreases degradation |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects response to substance |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects expression |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
decreases expression |
ISO |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nras |
neuroblastoma ras oncogene |
|
increases expression |
ISO |
2 |
198,292,650 |
198,300,286 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein, transcriptional regulator, 1 |
|
increases expression |
ISO |
1 |
185,770,310 |
185,772,313 |
RGD:6480464 |
CTD |
| G |
Pak1 |
p21 protein (Cdc42/Rac)-activated kinase 1 |
|
increases expression |
ISO |
1 |
155,057,622 |
155,174,714 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
increases expression |
ISO |
14 |
35,369,422 |
35,418,126 |
RGD:6480464 |
CTD |
| G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
|
decreases expression |
ISO |
4 |
75,929,398 |
75,948,299 |
RGD:6480464 |
CTD |
| G |
Pdpk1 |
3-phosphoinositide dependent protein kinase-1 |
|
increases phosphorylation |
ISO |
10 |
13,329,708 |
13,394,080 |
RGD:6480464 |
CTD |
| G |
Pfn1 |
profilin 1 |
|
decreases expression |
ISO |
10 |
57,531,661 |
57,534,366 |
RGD:6480464 |
CTD |
| G |
Pfn2 |
profilin 2 |
|
increases expression |
ISO |
2 |
147,066,815 |
147,072,519 |
RGD:6480464 |
CTD |
| G |
Pgd |
phosphogluconate dehydrogenase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pigr |
polymeric immunoglobulin receptor |
|
decreases expression |
ISO |
13 |
43,785,845 |
43,819,331 |
RGD:6480464 |
CTD |
| G |
Plk3 |
polo-like kinase 3 |
|
increases expression |
ISO |
5 |
137,443,540 |
137,448,715 |
RGD:6480464 |
CTD |
| G |
Ppp2ca |
protein phosphatase 2, catalytic subunit, alpha isozyme |
|
affects binding |
EXP |
10 |
37,621,256 |
37,641,008 |
RGD:6480464 |
CTD |
| G |
Ppp2ca |
protein phosphatase 2, catalytic subunit, alpha isozyme |
|
multiple interactions |
EXP |
10 |
37,621,256 |
37,641,008 |
RGD:6480464 |
CTD |
| G |
Ppp2r1a |
protein phosphatase 2, regulatory subunit A, alpha |
|
increases expression |
EXP |
1 |
58,442,220 |
58,461,462 |
RGD:6480464 |
CTD |
| G |
Ppp2r1a |
protein phosphatase 2, regulatory subunit A, alpha |
|
increases expression |
ISO |
1 |
58,442,220 |
58,461,462 |
RGD:6480464 |
CTD |
| G |
Ppp2r2a |
protein phosphatase 2, regulatory subunit B, alpha |
|
affects expression |
EXP |
15 |
46,546,447 |
46,605,977 |
RGD:6480464 |
CTD |
| G |
Prkd3 |
protein kinase D3 |
|
increases expression |
ISO |
6 |
1,727,315 |
1,796,290 |
RGD:6480464 |
CTD |
| G |
Ralb |
v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) |
|
increases expression |
ISO |
13 |
32,229,646 |
32,238,410 |
RGD:6480464 |
CTD |
| G |
Rhob |
ras homolog family member B |
|
increases expression |
ISO |
6 |
32,052,333 |
32,054,507 |
RGD:6480464 |
CTD |
| G |
Rhoc |
ras homolog family member C |
|
increases expression |
ISO |
2 |
200,048,056 |
200,054,107 |
RGD:6480464 |
CTD |
| G |
Rhoq |
ras homolog family member Q |
|
increases expression |
ISO |
6 |
10,414,042 |
10,449,472 |
RGD:6480464 |
CTD |
| G |
Rit1 |
Ras-like without CAAX 1 |
|
increases expression |
ISO |
2 |
180,846,683 |
180,859,135 |
RGD:6480464 |
CTD |
| G |
S100a11 |
S100 calcium binding protein A11 |
|
increases expression |
ISO |
2 |
186,620,360 |
186,621,911 |
RGD:6480464 |
CTD |
| G |
Serpinb6 |
serpin peptidase inhibitor, clade B (ovalbumin), member 6 |
|
increases expression |
ISO |
17 |
37,316,389 |
37,335,124 |
RGD:6480464 |
CTD |
| G |
Siah1a |
seven in absentia 1A |
|
increases expression |
ISO |
19 |
21,717,141 |
21,740,751 |
RGD:6480464 |
CTD |
| G |
Slc10a1 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
|
decreases expression |
ISO |
6 |
104,735,839 |
104,749,464 |
RGD:6480464 |
CTD |
| G |
Slc22a7 |
solute carrier family 22 (organic anion transporter), member 7 |
|
decreases expression |
ISO |
9 |
9,934,309 |
9,940,107 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
increases expression |
ISO |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a2 |
solute carrier organic anion transporter family, member 1A2 |
|
increases expression |
EXP |
4 |
179,790,209 |
179,851,288 |
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
decreases expression |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
multiple interactions |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
increases import |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
increases response to substance |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
increases response to substance |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
affects response to substance |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
increases response to substance |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
multiple interactions |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slco3a1 |
solute carrier organic anion transporter family, member 3a1 |
|
increases expression |
EXP |
1 |
129,580,126 |
130,077,110 |
RGD:6480464 |
CTD |
| G |
Slco6b1 |
solute carrier organic anion transporter family, member 6b1 |
|
increases expression |
EXP |
9 |
96,130,052 |
96,211,483 |
RGD:6480464 |
CTD |
| G |
Smoc2 |
SPARC related modular calcium binding 2 |
|
increases expression |
ISO |
1 |
53,165,792 |
53,295,145 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
decreases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Spint2 |
serine peptidase inhibitor, Kunitz type, 2 |
|
increases expression |
ISO |
1 |
84,393,845 |
84,416,299 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
decreases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Suclg2 |
succinate-CoA ligase, GDP-forming, beta subunit |
|
decreases expression |
ISO |
4 |
129,995,856 |
130,276,182 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
increases expression |
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases expression |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Thrsp |
thyroid hormone responsive |
|
decreases expression |
ISO |
1 |
154,647,339 |
154,651,663 |
RGD:6480464 |
CTD |
| G |
Tmsb10 |
thymosin, beta 10 |
|
increases expression |
ISO |
4 |
106,286,030 |
106,287,089 |
RGD:6480464 |
CTD |
| G |
Tmsb4x |
thymosin beta 4, X-linked |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
|
increases expression |
ISO |
10 |
12,940,334 |
12,942,343 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases phosphorylation |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
increases expression |
ISO |
8 |
71,331,304 |
71,358,063 |
RGD:6480464 |
CTD |
| G |
Treh |
trehalase (brush-border membrane glycoprotein) |
|
increases expression |
ISO |
8 |
47,631,777 |
47,645,166 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
increases expression |
ISO |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Ttr |
transthyretin |
|
decreases expression |
ISO |
18 |
12,406,571 |
12,413,680 |
RGD:6480464 |
CTD |
| G |
Tub |
tubby homolog (mouse) |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tub |
tubby homolog (mouse) |
|
decreases acetylation |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
increases expression |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Ugdh |
UDP-glucose 6-dehydrogenase |
|
increases expression |
ISO |
14 |
45,542,781 |
45,570,961 |
RGD:6480464 |
CTD |
| G |
Ugp2 |
UDP-glucose pyrophosphorylase 2 |
|
increases expression |
ISO |
14 |
102,072,724 |
102,113,561 |
RGD:6480464 |
CTD |
| G |
Upp2 |
uridine phosphorylase 2 |
|
increases expression |
ISO |
3 |
40,492,002 |
40,536,956 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
multiple interactions |
ISO |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
increases phosphorylation |
ISO |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Wee1 |
wee 1 homolog (S. pombe) |
|
increases expression |
ISO |
1 |
167,769,797 |
167,788,199 |
RGD:6480464 |
CTD |
| G |
Ywhag |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
|
increases expression |
ISO |
12 |
21,859,804 |
21,888,050 |
RGD:6480464 |
CTD |
| G |
Ywhah |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide |
|
increases expression |
ISO |
14 |
83,448,395 |
83,457,778 |
RGD:6480464 |
CTD |
| G |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
|
increases expression |
ISO |
7 |
72,283,825 |
72,306,126 |
RGD:6480464 |
CTD |
N-tosyl-L-phenylalanyl chloromethyl ketone
|
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
multiple interactions |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
multiple interactions |
ISO |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
affects localization |
ISO |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
decreases activity |
EXP |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
EXP |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
multiple interactions |
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases cleavage |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
decreases expression |
ISO |
8 |
4,649,559 |
4,667,733 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
multiple interactions |
ISO |
8 |
4,649,559 |
4,667,733 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
multiple interactions |
ISO |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
decreases expression |
ISO |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
increases expression |
ISO |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Hax1 |
HCLS1 associated protein X-1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hax1 |
HCLS1 associated protein X-1 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hax1 |
HCLS1 associated protein X-1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
decreases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Ikbkg |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
|
multiple interactions |
ISO |
X |
160,386,558 |
160,420,190 |
RGD:6480464 |
CTD |
| G |
Il17a |
interleukin 17A |
|
multiple interactions |
ISO |
9 |
19,454,979 |
19,458,467 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
multiple interactions |
ISO |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases activity |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects response to substance |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases degradation |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases phosphorylation |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
multiple interactions |
ISO |
1 |
83,865,440 |
83,873,010 |
RGD:6480464 |
CTD |
| G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
decreases phosphorylation |
ISO |
1 |
83,865,440 |
83,873,010 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
multiple interactions |
EXP |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
|
decreases expression |
EXP |
2 |
219,410,394 |
219,550,910 |
RGD:6480464 |
CTD |
| G |
Pdpk1 |
3-phosphoinositide dependent protein kinase-1 |
|
multiple interactions |
ISO |
10 |
13,329,708 |
13,394,080 |
RGD:6480464 |
CTD |
| G |
Pdpk1 |
3-phosphoinositide dependent protein kinase-1 |
|
decreases activity |
ISO |
10 |
13,329,708 |
13,394,080 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
decreases expression |
ISO |
15 |
3,680,072 |
3,686,232 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
affects activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
multiple interactions |
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Sts |
steroid sulfatase (microsomal), isozyme S |
|
multiple interactions |
ISO |
X |
63,915,803 |
63,923,834 |
RGD:6480464 |
CTD |
| G |
Tcf4 |
transcription factor 4 |
|
multiple interactions |
ISO |
18 |
66,135,863 |
66,359,984 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
decreases expression |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
multiple interactions |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
increases cleavage |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
neurotensin
|
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases activity |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases activity |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
multiple interactions |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
multiple interactions |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
increases activity |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases activity |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Ntsr1 |
neurotensin receptor 1 |
|
affects binding |
ISO |
3 |
169,567,488 |
169,633,121 |
RGD:6480464 |
CTD |
| G |
Ntsr2 |
neurotensin receptor 2 |
|
affects binding |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
oxytocin
|
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Mknk2 |
MAP kinase-interacting serine/threonine kinase 2 |
|
multiple interactions |
EXP |
7 |
10,550,040 |
10,561,100 |
RGD:6480464 |
CTD |
| G |
Noxo1 |
NADPH oxidase organizer 1 |
|
multiple interactions |
EXP |
10 |
13,949,293 |
13,953,880 |
RGD:6480464 |
CTD |
| G |
Oxtr |
oxytocin receptor |
|
multiple interactions |
EXP |
4 |
148,314,089 |
148,326,797 |
RGD:6480464 |
CTD |
| G |
Plcb1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
|
affects localization |
ISO |
3 |
122,797,718 |
123,523,675 |
RGD:6480464 |
CTD |
| G |
Plcb3 |
phospholipase C, beta 3 (phosphatidylinositol-specific) |
|
affects localization |
ISO |
1 |
209,628,425 |
209,643,694 |
RGD:6480464 |
CTD |
polymyxin B2
|
| G |
Cd80 |
Cd80 molecule |
|
multiple interactions |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
multiple interactions |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
multiple interactions |
EXP |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
multiple interactions |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
vasopressin
|
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
increases activity |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Mylk |
myosin light chain kinase |
|
affects response to substance |
EXP |
11 |
67,602,540 |
67,848,794 |
RGD:6480464 |
CTD |
Term paths to the root
|